EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Oral Immunisation With Non‐ GMO Surface Displayed SARS ‐ CoV ‐2 Spike Epitopes on Bacteria‐Like Particles Provokes Robust Humoral and Cellular Immune Responses, and Modulated the Gut Microbiome in Mice

Robie Vasquez iD, Ji Hoon Song iD, Remilyn M Mendoza iD, In-Chan Hwang iD, Bernadette B Bagon iD, Lars Engstrand iD, Valerie Diane Valeriano iD, Dae-Kyung Kang iD

Microbial Biotechnology · 2025

DOI: 10.1111/1751-7915.70073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Biotechnology, 2025. Verfasst von Robie Vasquez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Biotechnology, Dankook University, Cheonan, Korea. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Gastrointestinal Microbiome, COVID-19 Vaccines, SARS-CoV-2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET), Vetenskapsrådet (Swedish Research Council).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The coronavirus disease 2019 (COVID‐19) is a fatal disease caused by severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). To date, several vaccines have been developed to combat the spread of this virus. Mucosal vaccines using food‐grade bacteria, such as Lactobacillus spp., are promising strategies for developing safe and effective vaccines against SARS‐CoV‐2. In this study, we designed a non‐GMO surface‐displayed SARS‐CoV‐2 spike S1 epitope on Limosilactobacillus fermentum ‐derived bacteria‐like particles (BLPs). After that, we evaluated its efficacy to induce immune responses in immunocompetent mice. Moreover, we examined the influence of oral immunisation on the gut microbiome and microbiota metabolites. Twenty‐eight 6‐week‐old male C57BL/6 mice were orally immunised with the following: PBS (control), Lm. fermentum ‐derived BLPs only, BLPs displaying SARS‐CoV‐2 spike S1‐2, or BLPs displaying SARS‐CoV‐2 spike S1‐3 epitopes. Our results showed that mucosal immunisation of mice with surface‐displayed SARS‐CoV‐2 spike epitopes provoked high‐level secretory IgA and systemic IgG production. Moreover, the immunisation exhibited a Th1‐like immune response, characterised by an elevated IgG2a‐to‐IgG1 ratio and high antiviral IFN‐γ production. In addition, we observed gut microbiome modulation and increased butyrate production in immunised mice. Overall, the use of Lm. fermentum ‐derived BLPs and the anchor CshA to display SARS‐CoV‐2 spike S1epitopes is a promising novel strategy in developing a cost‐effective, non‐GMO mucosal vaccine alternative against SARS‐CoV‐2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusGastrointestinal MicrobiomeCOVID-19 VaccinesSARS-CoV-2EpitopesCOVID-19Immunity, CellularAnimalsMaleMiceMice, Inbred C57BLAdministration, OralLimosilactobacillus fermentumAntibodies, ViralImmunity, HumoralImmunization

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2bacteria‐like particlesimmune responselactobacillusmicrobiomemucosal vaccinesurface display

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2COVID-19 VaccinesEpitopesAntibodies, Viral

Autor:innen und Institutionen

  • Department of Animal Biotechnology, Dankook University, Cheonan, Korea.
  • Department of Microbiology, Tumor and Cell Biology, Centre for Translational Microbiome Research (CTMR), Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Robie Vasquez, Ji Hoon Song, Remilyn M Mendoza, In-Chan Hwang, Bernadette B Bagon, Lars Engstrand, Valerie Diane Valeriano, Dae-Kyung Kang

Förderung

  • National Research Foundation of Korea
  • Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET)
  • Vetenskapsrådet (Swedish Research Council)
  • Korea Institute of Planning and Evaluation for Technology in Food, Agriculture and Forestry

Zitieren

APA

Vasquez, R., Song, J. H., Mendoza, R. M., Hwang, I. C., Bagon, B. B., Engstrand, L., Valeriano, V. D., & Kang, D. K. (2025). Oral Immunisation With Non‐ GMO Surface Displayed SARS ‐ CoV ‐2 Spike Epitopes on Bacteria‐Like Particles Provokes Robust Humoral and Cellular Immune Responses, and Modulated the Gut Microbiome in Mice. Microbial Biotechnology. https://doi.org/10.1111/1751-7915.70073

Vancouver

Vasquez R, Song JH, Mendoza RM, Hwang IC, Bagon BB, Engstrand L, et al. Oral Immunisation With Non‐ GMO Surface Displayed SARS ‐ CoV ‐2 Spike Epitopes on Bacteria‐Like Particles Provokes Robust Humoral and Cellular Immune Responses, and Modulated the Gut Microbiome in Mice. Microbial Biotechnology. 2025. doi:10.1111/1751-7915.70073

BibTeX
@article{Vasquez2025,
  author = {Vasquez, Robie and Song, Ji Hoon and Mendoza, Remilyn M and Hwang, In-Chan and Bagon, Bernadette B and Engstrand, Lars and Valeriano, Valerie Diane and Kang, Dae-Kyung},
  title = {Oral Immunisation With Non‐ GMO Surface Displayed SARS ‐ CoV ‐2 Spike Epitopes on Bacteria‐Like Particles Provokes Robust Humoral and Cellular Immune Responses, and Modulated the Gut Microbiome in Mice},
  journal = {Microbial Biotechnology},
  year = {2025},
  doi = {10.1111/1751-7915.70073}
}
Kostenlos starten →